Rindex obtains license for AF prediction technology

05/1/2013 | MedCityNews.com

Rindex Medical has gained exclusive license from the Cleveland Clinic to develop the A-50 AF Prediction System, a tool that doctors can use to predict a patient's risk for atrial fibrillation after cardiac surgery. The Redwood City, Calif.-based startup has a working prototype of the device and is preparing to apply for 510(k) clearance.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA